DK0632033T3 - Nye benzopyranderivater - Google Patents

Nye benzopyranderivater

Info

Publication number
DK0632033T3
DK0632033T3 DK93902526T DK93902526T DK0632033T3 DK 0632033 T3 DK0632033 T3 DK 0632033T3 DK 93902526 T DK93902526 T DK 93902526T DK 93902526 T DK93902526 T DK 93902526T DK 0632033 T3 DK0632033 T3 DK 0632033T3
Authority
DK
Denmark
Prior art keywords
benzopyran derivatives
represent
hydroxy
new benzopyran
hydrogen
Prior art date
Application number
DK93902526T
Other languages
Danish (da)
English (en)
Inventor
Hiroshi Koga
Hiroyuki Nabata
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0632033T3 publication Critical patent/DK0632033T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK93902526T 1992-01-24 1993-01-25 Nye benzopyranderivater DK0632033T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1081992 1992-01-24
PCT/JP1993/000086 WO1993015068A1 (en) 1992-01-24 1993-01-25 Novel benzopyran derivative

Publications (1)

Publication Number Publication Date
DK0632033T3 true DK0632033T3 (da) 1999-10-18

Family

ID=11760967

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93902526T DK0632033T3 (da) 1992-01-24 1993-01-25 Nye benzopyranderivater

Country Status (15)

Country Link
US (1) US5646308A (es)
EP (1) EP0632033B1 (es)
JP (1) JP3260458B2 (es)
KR (1) KR100217167B1 (es)
CN (1) CN1036918C (es)
AT (1) ATE178601T1 (es)
AU (1) AU3367393A (es)
CA (1) CA2128603A1 (es)
DE (1) DE69324354T2 (es)
DK (1) DK0632033T3 (es)
ES (1) ES2132217T3 (es)
GR (1) GR3030581T3 (es)
SG (1) SG52734A1 (es)
WO (1) WO1993015068A1 (es)
ZA (1) ZA93436B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
ATE187331T1 (de) * 1993-04-23 1999-12-15 Chugai Pharmaceutical Co Ltd Benzopyranderivate
US5719155A (en) * 1993-11-10 1998-02-17 Japan Tobacco Inc. Chroman derivative and pharmaceutical use thereof
ES2139933T3 (es) * 1994-08-18 2000-02-16 Merck & Co Inc 2,3-dihidro-1-(2,2,2-trifluoroetil)-2-oxo-5-fenil-1h-1,4-benzodiacepinas.
JPH11506760A (ja) * 1995-06-07 1999-06-15 メルク エンド カンパニー インコーポレーテッド 新規なn−(2,4−ジオキソ−2,3,4,5−テトラヒドロ−1h−1,5−ベンゾジアゼピン−3イル)−3−アミド
US5726171A (en) * 1995-06-07 1998-03-10 Merck & Co Inc N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
US5631251A (en) * 1995-06-07 1997-05-20 Merck & Co., Inc. 5-cyclopropyl-1,4 benzodiazepine-2-ones
US5700797A (en) * 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
JP3076066B2 (ja) * 1996-08-27 2000-08-14 塩野義製薬株式会社 クロメン−3−カルボン酸誘導体
FR2756284B1 (fr) * 1996-11-26 2000-04-28 Adir Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TW533073B (en) * 1997-03-03 2003-05-21 Chugai Pharmaceutical Co Ltd Therapeutic agents for peripheral vascular disease
EP1004316B1 (en) * 1997-08-08 2005-11-02 Chugai Seiyaku Kabushiki Kaisha Therapeutics for diabetic complications
WO2000018754A1 (fr) * 1998-09-30 2000-04-06 Chugai Seiyaku Kabushiki Kaisha Procedes de preparation de derives de benzopyranne 4-substitue
CZ20013076A3 (cs) * 2000-08-29 2002-04-17 Kuraray Co., Ltd. Způsob výroby chromankarboxylové kyseliny
KR100602191B1 (ko) * 2004-03-10 2006-07-19 한국화학연구원 5-라이폭시게네이즈 저해활성을 가지는2,2'-이중치환-3,4-디하이드로-7,8-이중치환-6-알킬아미노벤조피란 유도체
WO2005105776A1 (en) * 2004-05-05 2005-11-10 F. Hoffmann-La Roche Ag Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both
US8604222B2 (en) 2004-07-30 2013-12-10 Forest Laboratories Holdings Limited Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
BRPI0519709A2 (pt) * 2004-12-21 2009-03-10 Hoffmann La Roche derivados de tetralina e indano e usos dos mesmos como antagonistas de 5-ht
WO2006066745A1 (en) * 2004-12-21 2006-06-29 F.Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN101119965B (zh) * 2004-12-21 2012-09-26 弗·哈夫曼-拉罗切有限公司 萘满和茚满衍生物及其用途
JP4738418B2 (ja) 2004-12-21 2011-08-03 エフ.ホフマン−ラ ロシュ アーゲー クロマン誘導体及びcns障害の処置におけるその使用
CA2592001A1 (en) * 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-ht receptor ligands
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(n-메틸치환술폰아미도)메틸-2h-1-벤조피란 유도체
KR100984897B1 (ko) * 2005-11-03 2010-10-01 에프. 호프만-라 로슈 아게 5-ht6 억제제로서 아릴설포닐 크로만
WO2007147763A1 (en) * 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Arylsulfonyl naphthalene derivatives and uses thereof
BRPI0713502A2 (pt) * 2006-06-20 2012-03-13 F. Hoffmann-La Roche Ag derivados de tetralina de arilsulfonamidil e empregos destes
AU2007263084A1 (en) * 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH619701A5 (es) * 1975-08-07 1980-10-15 Bayer Ag
JPS57167981A (en) * 1981-04-08 1982-10-16 Kowa Co Benzopyran derivative
GB8911280D0 (en) * 1989-05-17 1989-07-05 Beecham Group Plc Novel compounds
AU8230891A (en) * 1990-07-27 1992-03-02 Chugai Seiyaku Kabushiki Kaisha Novel benzopyran derivative

Also Published As

Publication number Publication date
JPH05294954A (ja) 1993-11-09
ZA93436B (en) 1993-08-25
GR3030581T3 (en) 1999-10-29
SG52734A1 (en) 1998-09-28
CA2128603A1 (en) 1993-08-05
DE69324354D1 (de) 1999-05-12
KR950700277A (ko) 1995-01-16
WO1993015068A1 (en) 1993-08-05
CN1036918C (zh) 1998-01-07
CN1077954A (zh) 1993-11-03
DE69324354T2 (de) 1999-11-25
KR100217167B1 (ko) 1999-09-01
EP0632033A1 (en) 1995-01-04
US5646308A (en) 1997-07-08
AU3367393A (en) 1993-09-01
EP0632033B1 (en) 1999-04-07
JP3260458B2 (ja) 2002-02-25
EP0632033A4 (es) 1995-02-01
ES2132217T3 (es) 1999-08-16
ATE178601T1 (de) 1999-04-15

Similar Documents

Publication Publication Date Title
DK0632033T3 (da) Nye benzopyranderivater
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
TW258735B (es)
FI915920A0 (fi) Serotoninantagonister.
ES2119017T3 (es) Derivados que contienen azufre de 2-ciano-1,3-dionas y su uso como herbicidas.
FR15C0027I2 (fr) Derives de pyrazolinone
DE69128477T2 (de) Benzopyranderivat
PT947504E (pt) Derivados de vitamina d 16-eno
ES2115003T3 (es) Aminocicloalcanobenzodioxoles como agentes adrenergicos selectivos beta-3.
ES2120498T3 (es) Nuevo compuesto tetraciclico.
ATE160357T1 (de) Neues antibiotikum, deoxymulündocandin, verfahren zu seiner produktion und verwendung als medikament
ES2099941T3 (es) Derivado de 3,4'-didesoxi-micaminosiltilonolido y su produccion.
ATE91033T1 (de) Photochromische zusammensetzung und diese zusammensetzung enthaltende gegenstaende.
ES2059928T3 (es) Ciclopropanotiocarboxiamidas.
DE69316903T2 (de) Saintopin derivate